I've been involved with the lead-up to this Dec. 2 meeting via working with both Fight CRC and CRI. I have hopes of the productive discussion that will occur when so many CRC & immunotherapy experts from a wide range of research institutions and companies are all sitting together, this kind of large joint round table meeting has never happened before.
-DK
Pasted from the link at the bottom:
On December 2, the two organizations will bring together over 20 global experts in immunotherapy, GI oncology and basic science in New York City for a discussion on the current state of science and the future direction of immunotherapy research for colorectal cancer therapies. A white paper, Evaluating the role of immunotherapy: Addressing the potential for breakthrough treatments for colorectal cancer, will be released in April 2016 following the American Association of Cancer Research annual meeting. -
Rallying Leading Experts
A multidisciplinary group will be led by Dung T. Le, M.D., from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, and Al B. Benson III, M.D., FACP, from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. It will be the first time the following leading experts in colorectal cancer immunotherapy research have all convened around the same table:
Dr. Al Benson, Northwestern University
Dr. Emily Chan, Vanderbilt University
Dr. Dustin Deming, University of Wisconsin
Dr. Luis Diaz, Johns Hopkins
Dr. Wolf Fridman, INSERM
Dr. Franck Housseau, Johns Hopkins
Dr. S. Peter Kang, Merck
Dr. Smitha Krishnamurth, Case Western University
Dr. Dung T Le, Johns Hopkins
Dr. Wells Messersmith, University of Colorado
Dr. Cynthia L. Sears, Johns Hopkins
Dr. Neil Segal, Memorial Sloan Kettering Cancer Center
Dr. Arvin Yang, Bristol-Myers Squibb
Dr. Rebecca Moss, Bristol-Myers Squibb
Dr. Edward Cha, Genentech
Dr. Tom Dubensky, Aduro Biotech
Dr. Dirk Brockstedt, Aduro Biotech
http://www.cancerresearch.org/news/2015 ... unotherapy